Original Research

Published on 01 Jun 2023

Triptolide enhances carboplatin-induced apoptosis by inhibiting nucleotide excision repair (NER) activity in melanoma

in Pharmacology of Anti-Cancer Drugs

Geng Wang
Hongmin Guo
Yan Ren
Weiyi Chen
Yixuan Wang
Jianing Li
Hua Liu
Jingjun Xing
Yanru Zhang
Na Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1157433

2,082 views
6 citations

Original Research

Published on 01 Jun 2023

Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreatic cancer

in Pharmacology of Anti-Cancer Drugs

Zelin Hou
Jiajing Lin
Yuan Ma
Haizhong Fang
Yuwei Wu
Zhijiang Chen
Xianchao Lin
Fengchun Lu
Shi Wen
Xunbin Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1193791

5,616 views
5 citations

Original Research

Published on 01 Jun 2023

Tanshinone IIA promotes vascular normalization and boosts Sorafenib’s anti-hepatoma activity via modulating the PI3K-AKT pathway

in Pharmacology of Anti-Cancer Drugs

Chengdong Qin
Siyuan Liu
Shiqi Zhou
Xianghou Xia
Jiejie Hu
Yang Yu
Dening Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1189532

2,463 views
2 citations

Systematic Review

Published on 01 Jun 2023

Efficacy and safety of pharmacotherapy for recurrent high-grade glioma: a systematic review and network meta-analysis

in Pharmacology of Anti-Cancer Drugs

Yanan Xu
Haijing Guan
Kefu Yu
Nan Ji
Zhigang Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1191480

3,185 views
4 citations

Original Research

Published on 31 May 2023

Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo

in Pharmacology of Anti-Cancer Drugs

Bharathi M. Rajamani
Raveen Stephen Stallon Illangeswaran
Esther Sathya Bama Benjamin
Balaji Balakrishnan
Daniel Zechariah Paul Jebanesan
Saswati Das
Aswin Anand Pai
Rakhi Thalayattu Vidhyadharan
Ajith Mohan
Sreeja Karathedath

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1187066

2,765 views
4 citations

Original Research

Published on 31 May 2023

Thymoquinone affects the gemcitabine sensitivity of pancreatic cancer by regulating collagen via hypoxia inducible factor-1α

in Pharmacology of Anti-Cancer Drugs

Zhanxue Zhao
Linxun Liu
Hekai Chen
Shuai Li
Yan Guo
Xiaofan Hou
Jinyu Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1138265

2,508 views
1 citation

Original Research

Published on 31 May 2023

Computational and experimental pharmacology to decode the efficacy of Theobroma cacao L. against doxorubicin-induced organ toxicity in EAC-mediated solid tumor-induced mice

in Pharmacology of Anti-Cancer Drugs

Priyanka P. Patil
Pranjal Kumar
Pukar Khanal
Vishal S. Patil
Harish R. Darasaguppe
Vishwambhar Vishnu Bhandare
Arati Bhatkande
Sudhanshu Shukla
Rajesh K. Joshi
Basanagouda M. Patil

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1174867

2,529 views
5 citations

Original Research

Published on 30 May 2023

Acute osimertinib exposure induces electrocardiac changes by synchronously inhibiting the currents of cardiac ion channels

in Pharmacology of Anti-Cancer Drugs

Peiwen Li
Xiaohui Tian
Gongxin Wang
Enshe Jiang
Yanming Li
Guoliang Hao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1177003

2,849 views
6 citations

Hypothesis and Theory

Published on 30 May 2023

Will EGFRvIII and neuronal-derived EGFR be targets for imipramine?

in Pharmacology of Anti-Cancer Drugs

Zesheng Li
Bo Wang
Jianjian Wu
Lei Han

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1156492

1,952 views

Systematic Review

Published on 30 May 2023

Progress and prospects of targeted therapy and immunotherapy for urachal carcinoma

in Pharmacology of Anti-Cancer Drugs

Yang Zheng
Heling Peng
Xu Hu
Yong Ou
Dong Wang
Han Wang
Shangqing Ren

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1199395

2,707 views
2 citations

Review

Published on 30 May 2023

RIPK2: a promising target for cancer treatment

in Pharmacology of Anti-Cancer Drugs

Jieqiong You
Ying Wang
Haifeng Chen
Fang Jin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1192970

7,255 views
7 citations

Original Research

Published on 26 May 2023

Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: the fate of peripheral blood CD26+ leukemia stem cells

in Pharmacology of Anti-Cancer Drugs

Paola Pacelli
Adele Santoni
Anna Sicuranza
Elisabetta Abruzzese
Valentina Giai
Monica Crugnola
Mario Annunziata
Sara Galimberti
Alessandra Iurlo
Luigiana Luciano

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1194712

2,491 views
5 citations

Systematic Review

Published on 25 May 2023

The efficacy and safety of Trilaciclib in preventing chemotherapy-induced myelosuppression: a systematic review and meta-analysis of randomized controlled trials

in Pharmacology of Anti-Cancer Drugs

Jingyue Qiu
Dandan Sheng
Fei Lin
Peng Jiang
Ning Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1157251

3,967 views
3 citations

Original Research

Published on 25 May 2023

Black tea bioactive phytoconstituents realign NRF2 for anticancer activity in lung adenocarcinoma

in Pharmacology of Anti-Cancer Drugs

Suchisnigdha Datta
Anupam Bishayee
Dona Sinha

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1176819

5,330 views
2 citations

Review

Published on 24 May 2023

The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Dongming Li
Donghui Cao
Yingnan Cui
Yuanlin Sun
Jing Jiang
Xueyuan Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1201085

3,825 views
8 citations

Review

Published on 24 May 2023

Nanoparticles as drug delivery systems in the treatment of oral squamous cell carcinoma: current status and recent progression

in Pharmacology of Anti-Cancer Drugs

Shuxia Cui
Hanzhe Liu
Guanglin Cui

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1176422

4,524 views
7 citations

Navigation group

Articles

Triptolide enhances carboplatin-induced apoptosis by inhibiting nucleotide excision repair (NER) activity in melanoma

Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreatic cancer

Tanshinone IIA promotes vascular normalization and boosts Sorafenib’s anti-hepatoma activity via modulating the PI3K-AKT pathway

Efficacy and safety of pharmacotherapy for recurrent high-grade glioma: a systematic review and network meta-analysis

Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo

Thymoquinone affects the gemcitabine sensitivity of pancreatic cancer by regulating collagen via hypoxia inducible factor-1α

Computational and experimental pharmacology to decode the efficacy of Theobroma cacao L. against doxorubicin-induced organ toxicity in EAC-mediated solid tumor-induced mice

Acute osimertinib exposure induces electrocardiac changes by synchronously inhibiting the currents of cardiac ion channels

Will EGFRvIII and neuronal-derived EGFR be targets for imipramine?

Progress and prospects of targeted therapy and immunotherapy for urachal carcinoma

RIPK2: a promising target for cancer treatment

Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: the fate of peripheral blood CD26+ leukemia stem cells

The efficacy and safety of Trilaciclib in preventing chemotherapy-induced myelosuppression: a systematic review and meta-analysis of randomized controlled trials

Black tea bioactive phytoconstituents realign NRF2 for anticancer activity in lung adenocarcinoma

The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma

Nanoparticles as drug delivery systems in the treatment of oral squamous cell carcinoma: current status and recent progression